Publicaciones (35) Publicaciones en las que ha participado algún/a investigador/a

2003

  1. Adult stem cells for myocardial repair

    BASIC AND APPLIED MYOLOGY, Vol. 13, Núm. 1, pp. 15 - 22

  2. Antioxidant vitamins increase the collagen content and reduce MMP-1 in a porcine model of atherosclerosis: Implications for plaque stabilization

    Atherosclerosis, Vol. 167, Núm. 1, pp. 45-53

  3. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction

    European Heart Journal, Vol. 24, Núm. 22, pp. 2012-2020

  4. Autologous stem cell transplantation for primary refractory Hodgkin's disease: Results and clinical variables affecting outcome

    Annals of Oncology, Vol. 14, Núm. 5, pp. 745-751

  5. Complicaciones clínicas en una serie de pacientes con anticuerpos anticardiolipina

    Anales del sistema sanitario de Navarra, Vol. 26, Núm. 3, pp. 365-372

  6. Células madre adultas

    Anales del sistema sanitario de Navarra, Vol. 26, Núm. 3, pp. 345-356

  7. Different expression of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bed

    Atherosclerosis, Vol. 170, Núm. 2, pp. 269-276

  8. Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: A randomized, double-blind clinical trial

    Journal of Thrombosis and Haemostasis, Vol. 1, Núm. 3, pp. 425-432

  9. El factor von Willebrand como intermediario entre la hemostasia y la angiogénesis de origen tumoral.

    Revista de medicina, Vol. 47, Núm. 3, pp. 22-28

  10. Estabilización de la placa de ateroma: Un nuevo concepto basado en la biología dinámica de la aterosclerosis

    Medicina Clinica, Vol. 121, Núm. 15, pp. 583-587

  11. Evaluation of the factor V HR2 haplotype as a risk factor for ischemic cerebrovascular disease

    Haematologica, Vol. 88, Núm. 2, pp. 236-237

  12. Granulocytic sarcoma (chloroma) of the lung

    British Journal of Haematology, Vol. 120, Núm. 2, pp. 176

  13. Hemostasia, angiogénesis y cáncer: Papel del factor von Willebrand

    Revista Clinica Espanola, Vol. 203, Núm. 4, pp. 199-201

  14. High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: The GEL-TAMO experience

    Annals of Oncology, Vol. 14, Núm. 12, pp. 1768-1775

  15. High-dose therapy in diffuse large cell lymphoma: Results and prognostic factors in 452 patients from the GEL-TAMO Spanish cooperative group

    Annals of Oncology, Vol. 14, Núm. 1, pp. 140-151

  16. In vitro and in vivo comparative study of chimeric liver-specific promoters

    Molecular Therapy, Vol. 7, Núm. 3, pp. 375-385

  17. Independent association of fibrinogen with carotid intima-media thickness in asymptomatic subjects

    Cerebrovascular Diseases, Vol. 16, Núm. 4, pp. 356-362

  18. Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response

    Haematologica, Vol. 88, Núm. 12, pp. 1425-1426

  19. Major bleeding during combined treatment with indomethacin and low doses of acenocoumarol in a homozygous patient for 2C9*3 variant of cytochrome P-450 CYP2C9

    Thrombosis and Haemostasis

  20. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow

    Blood, Vol. 102, Núm. 8, pp. 3043-3051